Catalent To Purchase Bristol-Myers Squibb Manufacturing Facility In Italy

Catalent Inc CTLT will purchase a Bristol-Myers Squibb BMY manufacturing facility in Anagni, Italy.

No terms have been disclosed yet.

On Wednesday, Catalent shares traded down 0.4% to $50.40. Bristol-Myers Squibb shares traded up 0.59% at $48.05.

Related links:

Nikkei: Apple Could Shift Some Production Capacity Out Of China

My Size Rallies On Integration With 'Global' Apparel Company's E-Commerce Platform